Randomized phase II trial of All-trans-retinoic acid with chemotherapy based on paclitaxel and cisplatin as first-line treatment in patients with advanced non-small-cell lung cancer.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Clinical Oncology

• Publication date

  2010-07-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2009.26.6452PMID 20547984
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Statistics, 2009

  2009cited by this paper
• Beyond doublet chemotherapy for advanced non-small-cell lung cancer: combination of targeted agents with first-line chemotherapy.

  2009cited by this paper
• Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.

  2008cited by this paper
• Role of retinoic receptors in lung carcinogenesis

  2008cited by this paper
• A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.

  2008cited by this paper
• Phase III trial comparing carboplatin, paclitaxel, and bexarotene with carboplatin and paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT II.

  2008cited by this paper
• Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145

  2008cited by this paper
• Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma

  2007cited by this paper
• Retinoids in biological control and cancer

  2007cited by this paper
• Tumor-suppressive activity of retinoic acid receptor-β in cancer

  2007cited by this paper
• Retinoic acid in the development, regeneration and maintenance of the nervous system

  2007cited by this paper
• Tumor-suppressive activity of retinoic acid receptor-beta in cancer.

  2007cited by this paper
• Promising results achieved with a combination of chemotherapy and two retinoids in patients with advanced non-small-cell lung cancer.

  2006cited by this paper
• Antitumor effects of all‐trans‐retinoic acid on cultured human pancreatic cancer cells

  2006cited by this paper
• Emerging role of rexinoids in non-small cell lung cancer: focus on bexarotene.

  2005cited by this paper
• Expression profiles of Id1 and p16 proteins in all-trans-retinoic acid-induced apoptosis and cell cycle re-distribution in melanoma.

  2005cited by this paper
• Synergistic effect of all-trans-retinoic acid and arsenic trioxide on growth inhibition and apoptosis in human hepatoma, breast cancer, and lung cancer cells in vitro.

  2005cited by this paper
• Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection?

  2005cited by this paper
• A phase II trial of a differentiating agent (tRA) with cisplatin-VP 16 chemotherapy in advanced non-small cell lung cancer

  2004cited by this paper
• Retinoids: potential in cancer prevention and therapy

  2004cited by this paper
• Clinicopathological significance of aberrant methylation of RARbeta2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancer.

  2004cited by this paper
• Suppression of telomerase activity and arrest at G1 phase in human cervical cancer HeLa cells by all‐trans retinoic acid

  2004cited by this paper
• Anti-tumor effect of vitamin A and D on head and neck squamous cell carcinoma.

  2003cited by this paper
• Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer.

  2002cited by this paper
• Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.

  2002cited by this paper
• Retinoids and their receptors in cancer development and chemoprevention.

  2002cited by this paper
• Advances in the understanding and management of acute promyelocytic leukemia.

  2002cited by this paper
• Retinoids in combination therapies for the treatment of cancer: mechanisms and perspectives.

  2002cited by this paper
• Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial.

  2002cited by this paper
• Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer.

  2001cited by this paper
• Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis.

  2001cited by this paper
• Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.

  2001cited by this paper
• Retinoids in chemoprevention and differentiation therapy.

  2000cited by this paper
• Orphan Receptor COUP-TF Is Required for Induction of Retinoic Acid Receptor β, Growth Inhibition, and Apoptosis by Retinoic Acid in Cancer Cells

  2000cited by this paper
• Evidence That Retinoic Acid Receptor β Induction by Retinoids Is Important for Tumor Cell Growth Inhibition*

  2000cited by this paper
• Early effects of retinoic acid on proliferation, differentiation and apoptosis in non-small cell lung cancer cell lines.

  1999cited by this paper
• Expression of retinoid receptor genes and proteins in non-small-cell lung cancer.

  1999cited by this paper
• Differentiation and antiproliferation effects of retinoic acid receptor beta in hepatoma cells.

  1998cited by this paper
• [Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia].

  1997cited by this paper
• all-trans retinoic acid enhances cisplatin-induced apoptosis in human ovarian adenocarcinoma and in squamous head and neck cancer cells.

  1997cited by this paper
• Phase I clinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamics

  1997cited by this paper
• Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia.

  1996cited by this paper
• A decade of molecular biology of retinoic acid receptors

  1996cited by this paper
• Phase II trial of all-trans retinoic acid in metastatic non-small cell lung cancer.

  1996cited by this paper
• Phase II study of all-trans-retinoic acid and alpha-interferon in patients with advanced non-small cell lung cancer.

  1995cited by this paper
• Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemia

  1993cited by this paper
• Human lung cancer cell lines exhibit resistance to retinoic acid treatment.

  1993cited by this paper
• Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemia.

  1993cited by this paper
• Expression and regulation of retinoic acid receptors in human breast cancer cells.

  1992cited by this paper
• Characterization of an autoregulated response element in the mouse retinoic acid receptor type beta gene.

  1990cited by this paper
• Fleiss, J. L.: Statistical Methods for Rates and Proportions. John Wiley & Sons, New York‐London‐Sydney‐Toronto 1973. XIII, 233 S.

  1974cited by this paper
• Statistical methods for rates and proportions

  1973cited by this paper

• Modeling CAF-tumor interactions to overcome therapy resistance

  2026cites this paper
• The role of RARG in solid tumor progression and therapeutic potential.

  2026cites this paper
• CBFA2T3 as a Key Prognostic Biomarker in Lung Adenocarcinoma: Insights from Comprehensive Analysis and Validation.

  2025cites this paper
• Retinoic Acid Reprograms Mast Cells Toward a Proinflammatory State to Enhance Antitumor Immunity

  2025cites this paper
• Insights into the relevance of targeting fibroblasts to control cancer

  2025cites this paper
• Combination of hydralazine and all-trans retinoic acid targeting breast cancer cells

  2025cites this paper
• AP-2α decreases TMZ resistance of recurrent GBM by downregulating MGMT expression and improving DNA damage.

  2024cites this paper
• Tretinoin improves the anti-cancer response to cyclophosphamide, in a model-selective manner

  2024cites this paper
• All-trans Retinoic Acid Sensitizes Epithelial Ovarian Cancer to PARP Inhibition after Exposure to Cisplatin

  2024cites this paper
• Pin1-catalyzed conformational regulation after phosphorylation: A distinct checkpoint in cell signaling and drug discovery

  2024cites this paper
• Novel Cellular Functions of ATR for Therapeutic Targeting: Embryogenesis to Tumorigenesis

  2023cites this paper
• All‐Trans Retinoic Acid Promotes a Tumor Suppressive OTUD6B‐β‐TrCP‐SNAIL Axis in Esophageal Squamous Cell Carcinoma and Enhances Immunotherapy

  2023cites this paper
• Exploiting innate immunity for cancer immunotherapy

  2023cites this paper
• CLMP is a tumor suppressor that determines all-trans retinoic acid response in colorectal cancer.

  2023cites this paper
• Fast proliferating and slowly migrating non‐small cell lung cancer cells are vulnerable to decitabine and retinoic acid combinatorial treatment

  2023cites this paper
• Characterization and therapeutic perspectives of differentiation-inducing therapy in malignant tumors

  2023cites this paper
• Proline Isomerization: From the Chemistry and Biology to Therapeutic Opportunities

  2023cites this paper
• Targeting the tumor stroma for cancer therapy

  2022cites this paper
• Safety and efficacy of MIKE-1 in patients with advanced pancreatic cancer: a study protocol for an open-label phase I/II investigator-initiated clinical trial based on a drug repositioning approach that reprograms the tumour stroma

  2022cites this paper
• Retinoids in cancer chemoprevention and therapy: Meta-analysis of randomized controlled trials

  2022cites this paper
• A systematic review of oral retinoids for treatment of acneiform eruptions induced by epidermal growth factor receptor inhibitors

  2022cites this paper
• Sphingosine kinases are involved in the regulation of all-trans retinoic acid sensitivity of K562 chronic myeloid leukemia cells.

  2021cites this paper
• The role of myeloid-derived suppressor cells in lung cancer and targeted immunotherapies

  2021cites this paper
• Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy

  2021cites this paper
• Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer

  2021cites this paper
• Retinoids as Chemo-Preventive and Molecular-Targeted Anti-Cancer Therapies

  2021cites this paper
• Protective role of All Trans Retinoic Acid on B16F10 melanoma cell line metastasis in C57BL/6 mice by enhancing RAR- β protein and homeostasis maintenance

  2021cites this paper
• All-trans retinoic acid in anticancer therapy: how nanotechnology can enhance its efficacy and resolve its drawbacks

  2021cites this paper
• The impacts of race and regimens on the efficacy and safety of paclitaxel and platinum combination treatment for patients with advanced non-small cell lung cancer

  2021cites this paper
• Exploitation of the vitamin A/retinoic acid axis depletes ALDH1-positive cancer stem cells and re-sensitises resistant non-small cell lung cancer cells to cisplatin

  2021cites this paper
• Targeting Myeloid-Derived Suppressor Cells in Ovarian Cancer

  2021cites this paper
• Tissue and serum metabolomic phenotyping for diagnosis and prognosis of hepatocellular carcinoma

  2020cites this paper
• STRA6 Polymorphisms Are Associated With EGFR Mutations in Locally-Advanced and Metastatic Non-Small Cell Lung Cancer Patients

  2020cites this paper
• Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer

  2020cites this paper
• Cellular retinol binding protein 1 transfection reduces proliferation and AKT-related gene expression in H460 non-small lung cancer cells

  2020cites this paper
• Novel strategies of Raman imaging for monitoring intracellular retinoid metabolism in cancer cells

  2020cites this paper
• Phosphorylation-Dependent Pin1 Isomerization of ATR: Its Role in Regulating ATR’s Anti-apoptotic Function at Mitochondria, and the Implications in Cancer

  2020cites this paper
• Antitumor effects of all-trans retinoic acid and its synergism with gemcitabine are associated with downregulation of p21-activated kinases in pancreatic cancer.

  2019cites this paper
• The Effect of Arsenic Trioxide on All-trans Retinoic Acid Binding to Human Serum Albumin

  2019cites this paper
• Cellular Retinol Binding Protein I transfection in H460 non-small lung carcinoma cells reduces proliferation and AKT-related gene expression

  2019influential citation
• Retinoic acid downregulates thiol antioxidant defences and homologous recombination while promotes A549 cells sensitization to cisplatin.

  2019cites this paper
• The potential of retinoids for combination therapy of lung cancer: updates and future directions.

  2019cites this paper
• A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method

  2019cites this paper
• Immunomodulator polyinosinic-polycytidylic acid enhances the inhibitory effect of 13-cis-retinoic acid on neuroblastoma through a TLR3-related immunogenic-apoptotic response

  2019cites this paper
• Combinational treatment of all-trans retinoic acid (ATRA) and bisdemethoxycurcumin (BDMC)-induced apoptosis in liver cancer Hep3B cells.

  2019cites this paper
• Microalgal Derivatives as Potential Nutraceutical and Food Supplements for Human Health: A Focus on Cancer Prevention and Interception

  2019cites this paper
• Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy

  2018cites this paper
• FT-IR- and Raman-based biochemical profiling of the early stage of pulmonary metastasis of breast cancer in mice.

  2018cites this paper
• New Insights in Cushing Disease Treatment With Focus on a Derivative of Vitamin A

  2018cites this paper
• Genistein Affects Expression of Cytochrome P450 (CYP450) Genes in 
Hepatocellular Carcinoma (HEPG2/C3A) Cell Line

  2018cites this paper
• Myeloid-derived suppressor cells and their role in gynecological malignancies

  2018cites this paper
• Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells

  2018cites this paper
• Targeting myeloid‐derived suppressor cells using all‐trans retinoic acid in melanoma patients treated with Ipilimumab

  2018cites this paper
• The success and the challenge of all-trans retinoic acid in the treatment of cancer

  2018cites this paper
• All‐trans retinoic acid reverses epithelial‐mesenchymal transition in paclitaxel‐resistant cells by inhibiting nuclear factor kappa B and upregulating gap junctions

  2018cites this paper
• Efficiency of All-Trans Retinoic Acid on Gastric Cancer: A Narrative Literature Review

  2018cites this paper
• Genes Correlated with Gemcitabine Efficacy in Non-small Cell Lung Cancer

  2018cites this paper
• Chemical or genetic Pin1 inhibition exerts potent anticancer activity against hepatocellular carcinoma by blocking multiple cancer-driving pathways

  2017cites this paper
• Targeting myeloid derived suppressor cells with all-trans retinoic acid is highly time-dependent in therapeutic tumor vaccination

  2017cites this paper
• Preparation and in vitro characterization of retinoic acid-loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) micelles

  2017cites this paper
• Pharmacokinetics and Physiologically Based Pharmacokinetic Modeling of Xenobiotic Disposition in Special Populations

  2017cites this paper
• Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma

  2017cites this paper
• The clinical evidence for targeting human myeloid‐derived suppressor cells in cancer patients

  2017influential citation
• Physiologically Based Pharmacokinetic Model of All-trans-Retinoic Acid with Application to Cancer Populations and Drug Interactions

  2017cites this paper
• Synthesis of short retinoidal amides related to fenretinide: antioxidant activities and differentiation-inducing ability

  2017cites this paper
• Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells

  2017cites this paper
• Exploring the reactivity of retinol radical cation toward organic and biological molecules: A laser flash photolysis study.

  2017cites this paper
• Deregulation of RBP4 and RBP7 Genes in Clear Cell Renal Cell Carcinoma

  2017cites this paper
• Pro-apoptotic signaling induced by Retinoic acid and dsRNA is under the control of Interferon Regulatory Factor-3 in breast cancer cells

  2017cites this paper
• Enhanced expression of tumour suppressor RAR‐&bgr; by DSPC nano‐formulated lipo‐ATRA in the lung of B16F10 cell‐implanted C57BL6 mice and in A549 cells

  2017cites this paper
• Association between nuclear expression of retinoic acid receptor alpha and beta and clinicopathological features and prognosis of advanced non-small cell lung cancer

  2016cites this paper
• Retinoids and rexinoids in cancer prevention: from laboratory to clinic.

  2016cites this paper
• Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines.

  2016cites this paper
• All-trans retinoic acid potentiates cisplatin-induced kidney injury in rats: impact of retinoic acid signaling pathway

  2016cites this paper
• Abnormal expression of genes that regulate retinoid metabolism and signaling in non-small-cell lung cancer

  2016cites this paper
• The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target

  2016cites this paper
• Retinoic acid receptors: from molecular mechanisms to cancer therapy.

  2015cites this paper
• Vitamin A, Cancer Treatment and Prevention: The New Role of Cellular Retinol Binding Proteins

  2015cites this paper
• Nuclear Retinoic Acid Receptors : Retinoic Acid Receptors ( RARs ) and Retinoid X Receptors ( RXRs

  2015cites this paper
• Advances in the Use of Retinoids in Cancer Therapy and Prevention

  2015cites this paper
• Alterations in Retinoic Acid Receptors in Non-Small Cell Lung Cancer and Their Clinical Implications

  2015influential citation
• Minireview: Familiar Faces in Unfamiliar Places: The Emerging Role of Nuclear Receptors in Lung Cancer.

  2015cites this paper
• Synergistic effect of all‑trans retinoic acid in combination with protein kinase C 412 in FMS-like tyrosine kinase 3-mutated acute myeloid leukemia cells.

  2015cites this paper
• Epigenetic priming of non-small cell lung cancer cell lines to the antiproliferative and differentiating effects of all-trans retinoic acid

  2015cites this paper
• Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer

  2015cites this paper
• All-Trans Retinoic Acid-Induced Deficiency of the Wnt/β-Catenin Pathway Enhances Hepatic Carcinoma Stem Cell Differentiation

  2015cites this paper
• High ABCG4 Expression Is Associated with Poor Prognosis in Non-Small-Cell Lung Cancer Patients Treated with Cisplatin-Based Chemotherapy

  2015cites this paper
• ABC transporters in anticancer drug transport ? Lessons for Therapy,Drug Development and Delivery Systems

  2015cites this paper
• Combination Treatment with All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133+ Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung Cancer

  2015influential citation
• [Chemotherapy-induced Peripheral Neuropathy].

  2015cites this paper
• Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer

  2014cites this paper
• All-trans-retinoic acid counteract the tumor-stimulating effect of hepatectomy and increases survival of rats bearing liver metastases.

  2014cites this paper
• Preclinical evaluation of the PARP inhibitor, olaparib, in combination with cytotoxic chemotherapy in pediatric solid tumors

  2014cites this paper
• Evaluation of the Retinoids With Cisplatin and Vincristine in Xenograft Models of Neuroblastoma

  2014cites this paper
• Encapsulation in lipid-core nanocapsules overcomes lung cancer cell resistance to tretinoin.

  2014cites this paper
• Multiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (Review)

  2014cites this paper
• Title Page Molecular Pathways: Current Role and Future Directions of the Retinoic Acid Pathway In Cancer Prevention and Treatment Authors:

  2013cites this paper
• Involvement of TRPC Channels in Lung Cancer Cell Differentiation and the Correlation Analysis in Human Non-Small Cell Lung Cancer

  2013cites this paper
• Carotenoids and Vitamin A in Lung Cancer Prevention

  2013cites this paper
• Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer

  2013cites this paper